FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 34 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $28 | -99.8% | 2,921 | +34.2% | 0.00% | – |
| Q2 2022 | $12,000 | +300.0% | 2,177 | +142.2% | 0.00% | – |
| Q4 2021 | $3,000 | +200.0% | 899 | +273.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 241 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -83.3% | 241 | -77.8% | 0.00% | – |
| Q1 2021 | $6,000 | -57.1% | 1,086 | -44.6% | 0.00% | – |
| Q4 2020 | $14,000 | – | 1,960 | +1731.8% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 107 | -92.1% | 0.00% | – |
| Q2 2020 | $11,000 | – | 1,360 | +1260.0% | 0.00% | – |
| Q3 2019 | $0 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 2,407,357 | $18,079,251 | 17.55% |
| Solas Capital Management, LLC | 1,725,567 | $12,959,008 | 9.07% |
| DG Capital Management, LLC | 1,143,099 | $8,584,673 | 4.70% |
| HARBERT FUND ADVISORS, INC. | 466,869 | $3,506,186 | 2.56% |
| AIGH Capital Management LLC | 373,526 | $2,805,180 | 1.33% |
| Southpoint Capital Advisors LP | 4,077,214 | $30,619,877 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $525,700 | 0.68% |
| Worth Venture Partners, LLC | 92,636 | $695,696 | 0.41% |
| Lion Point Capital, LP | 110,000 | $826,100 | 0.37% |
| 683 Capital Management, LLC | 300,000 | $2,253,000 | 0.18% |